Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis

Inclusion Criteria: * Male and female outpatients aged ≥18 years * Signed informed consent form * Clinically diagnosed acute pharyngitis (TPA ≥5) * Recent onset of symptoms (≤24 hours) * Pain intensity of ≥8 on an 11-point NRS * Difficulty in swallowing (100-mm VAS ≥50 mm) Exclusion Criteria: * Patients with strong suspicion of streptococcus A infection (McIsaac score ≥3) * Positive rapid streptococcus A test (rapid antigen detection test) to exclude the major bacterial pathogen responsible for sore throat * Purulent tonsillitis * The use of systemic/local antibiotics in the throat area within 7 days prior to screening and during the study * The use of any systemic analgesics/local analgesics in the throat area (e.g. non-steroidal drugs, \[acetylsalicylic acid \>100 mg\], paracetamol) within 36 hours prior to screening and during the study * The use of local anaesthetics for treatment of sore throat within 2 days prior to screening and during the study * The use of any systemic anti-inflammatory drug/local anti-inflammatory drug in the throat area (e.g. glucocorticoids) within 4 weeks prior to screening and during the study * The use of any other 'sore throat medication' (e.g., lozenges, drops, sprays) or other 'cold medication' that could have interfered with the results of the study within 7 days prior to screening and during the study